UK Internet drug logo "useless," say experts
A proposal by the UK's Royal Pharmaceutical Society (which represents pharmacists) to authorize on-line suppliers of pharmaceutical products has been met with skepticism from experts in Internet security. Under the RPS proposal, on-line pharmacies that are based in the UK and which meet the standards of both the Society and the Medicines and Healthcare products Regulatory Agency (MHRA), would be permitted to display an approved logo on their web sites.
Supporters of the scheme point to the recently-reported case of a 64-year old woman from the UK who developed glaucoma and cataracts in her eyes after buying the oral steroid prednisone via the Internet from Thailand (Marketletter September 4). However, in the example given, there is no evidence that the quality of the drug was to blame. Worse still, an on-line pharmacy outside the UK would be able to copy the logo with impunity and even pretend to be based in the UK.
"Make people think they're safe"
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze